Indian Journal of Research in Homeopathy

EDITORIAL
Year
: 2020  |  Volume : 14  |  Issue : 3  |  Page : 169--170

COVID-19: What lies ahead for Homoeopathy?


Anil Khurana 
 Editor-in-Chief

Correspondence Address:
Dr. Anil Khurana
Editor-in-Chief




How to cite this article:
Khurana A. COVID-19: What lies ahead for Homoeopathy?.Indian J Res Homoeopathy 2020;14:169-170


How to cite this URL:
Khurana A. COVID-19: What lies ahead for Homoeopathy?. Indian J Res Homoeopathy [serial online] 2020 [cited 2020 Nov 26 ];14:169-170
Available from: https://www.ijrh.org/text.asp?2020/14/3/169/296249


Full Text



 COVID-19



A lot is being said and done about the role of alternative medical systems in these COVID-19 times. This includes Homoeopathy.[1],[2] The more people are realising about the role of immunity in fighting this illness, the more they are turning towards alternative sciences for protection.[3] This has been observed globally, with China being the first to put the use of Traditional Chinese Medicine in COVID-19 treatment on record.[4] With the WHO removing its previous advisory of not taking traditional herbal remedies for COVID-19, the global demand has also grown.[5] The potential role of AYUSH medicines in promoting immunity during COVID-19 has been internationally reported.[6] It is predicted that the use of Traditional and Complementary Medicine during the pandemic may result in the further global adoption of alternative medicine and possibly its long-term acceptance as mainstream medicine.[7]

The Homoeopathy sector has been quick and responsive to the need of humankind to offer preventive and curative treatment options. Homoeoprophylaxis studies are reported from Cuba [8] and India.[9],[10] Meanwhile, Arsenic album is being prescribed by many homoeopathic doctors the world over as the preventive for the illness in many parts of the world, as per the knowledge gathered by interacting within the professional circle. Interestingly, the clinical trials with Homoeopathy as an add-on to the standard of care in hospitalised cases of COVID-19 have also initiated eventually in some parts of the world, including India. These primarily refer to moderate and severe cases. Seeking permissions for such trials and getting clearance of the ethical committees of the hospitals for such trials is a task in itself. Nevertheless, our profession has risen to this opportunity and taken to the task of proving the role of Homoeopathy in the ongoing pandemic. There is, however, a need to address post-COVID sequelae which, in spite of getting negative coronavirus test, patients continue to suffer from respiratory complaints, weakness, myalgia, etc.[11],[12]

Every pandemic leaves humankind some lessons to learn from and opens a new chapter of information for the medical profession. With Homoeopathy making a palpable presence in this changing medical scenario during the 2020 pandemic, I am sure the road ahead for Homoeopathy is becoming broader, with more opportunities opening for scientific explorations, and a wider acceptance of people at large.

Our last issue on COVID-19 has been widely appreciated and referred to. It talked primarily of the possibilities that Homoeopathy has to offer in COVID-19, thus acting as a source of guidance, paving the way for future work. We sincerely acknowledge the wide reads our special issue received.

 In this Issue



In this issue, several original research articles are presented to the profession. Iron-deficiency anaemia is quite prevalent in the Indian population, and it is observed that homoeopathic biochemic medicines are used frequently in practice with good results for this condition. Hence, the council's scientists attempted to study whether Ferrum phosphoricum or Ferrum metallicum could bring about a change in the haemoglobin levels in a statistically significant manner. The findings of this study are presented in this issue.[13]

The findings of a randomised controlled trial are presented which attempted to examine the effect of pre-defined homoeopathic remedies as adjuvant versus placebo for the dermatological adverse effects of radiotherapy and vomiting after chemotherapy in breast carcinoma.[14]

A study was conducted to see if a longer Likert scale would perform better in homoeopathic prognostic factor research.[15] This study has been a continuation of the previous study [16] which has concluded that with a 5-point Likert scale, few symptoms even in moderate intensity precipitated higher prevalence in the general population. Consequently, a need of longer Likert scales (more cut-off values), i.e., a 7-point Likert scale, was warranted.

The findings of another pilot study are presented, which was conducted at ten centres under the council, to study the response of homoeopathic medicines in cases of chronic cough by the method of prognostic factor research.[17] Such evolving research methods aid in improving the homoeopathic method and its practical use.

Two case reports of evidence-based medicine are presented in this issue. One is the case of a patient suffering from nodular episcleritis who responded to the homoeopathic remedy prescribed on the basis of totality of symptoms and his condition resolved within a week.[18] The second case report narrates how adjuvant homoeopathic treatment helped prevent tracheal stent implantation surgery, otherwise deemed necessary in case of post-intubation subglottic stenosis and improved the overall general state of the patient.[19]

The significant research published in the first half of this year is summarised in the research updates section.[20] A book review of the two volumes of the Standard Treatment Guidelines published by the council is also presented.[21] These guidelines provide standardised guidance of diagnosis and therapeutic management of a diseased condition with Homoeopathy and are quite popular with the homoeopathic fraternity.

Here's wishing our readers good, holistic health!

References

1Ali I, Alharbi OML. COVID-19: Disease, management, treatment, and social impact. Sci Total Environ 2020;728:138861.
2Kalliantas D, Kallianta M, Karagianni CS. Homeopathy combat against coronavirus disease (COVID-19). Z Gesundh Wiss 2020:1-4. doi: 10.1007/s10389-020-01305-z [Epub ahead of print].
3Nilashi M, Samad S, Yusuf SYM, Akbari E. Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function? J Infect Public Health 2020;13:893-6.
4Yang YC. Traditional Chinese medicine for COVID-19. Rapid response to: Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: Retrospective case series. BMJ 2020;368:m606. Available from: https://www.bmj.com/content/368/bmj.m606/rr-13. [Last accessed on 2020 Sep11].
5Available from: https://www.globaltimes.cn/content/1182110.shtml.
6Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: A promising cure for the global panic. Sci Total Environ 2020;725:138277.
7Available from: https://www.beltandroad.news/2020/06/27/could-covid-19-bring-shift-in-alternative-medicine-industry/. [Last accessed on 2020 Sep11].
8Available from: https://apps.who.int/trialsearch/Trial2.aspx?TrialID= RPCEC00000312. [Last accessed on 2020 Sep11].
9Azis S, Kaur H. Enabling use of Homoeopathy in India's preparedness for pandemic/epidemic situation like COVID-19 Indian J Res Homoeopathy 2020;14:143-51.
10Thomas MV, Sivaraman Nirmal GO, Bijukumar D, Muraleedharan KC, Biju SG. Efficacy of Arsenicum alb 30c for upregulating immunological markers among residents of COVID-19 related hot spot areas in Pathanamthitta, Kerala. 2020;129.. [Doi: 10.13140/rg. 2.2.26387.71200].
11Liu D, Zhang W, Pan F, Li L, Yang L, Zheng D, et al. The pulmonary sequalae in discharged patients with COVID-19: A short-term observational study. Respir Res 2020;21:125.
12Garg RK. Spectrum of neurological manifestations in COVID-19: A review. Neurol India 2020;68:560-72.
13Khurana A, Mittal R, Rath P, Moorthy K, Taneja D, Singh U, et al. Ferrum phosphoricum 3X and Ferrum metallicum 3X in the treatment of iron deficiency anaemia in children: Randomized parallel arm study. Indian J Res Homoeopathy 2020;14:171-78.
14Shukla P, Nayak C, Baig MQ, Misra P. Effects of pre-defined homoeopathic medicines to mitigate adverse dermatological effects of radiotherapy and vomiting of chemotherapy in breast carcinoma: A randomised, double--blind, placebo-controlled, pilot trial in the context of usual care. Indian J Res Homoeopathy 2020;14:189-199.
15Shinde VH, Rutten L, Khurana A, Manchanda RK, Bawaskar RS. Prevalence of homoeopathic polar symptoms: A follow-up pilot study conducted in Mumbai in 2017. Indian J Res Homoeopathy 2020;14:179-88.
16Rutten L, Muraleedharan KC, Shinde VH, Manchanda RK. What is a homoeopathic symptom, in daily practice and research? Indian J Res Homoeopathy 2017;11:11-20.
17Kaur H, Lamba CD, Sachdeva J, Rutten L, Khurana A, Oberai P, et al. Optimising the use of polar symptoms in Homoeopathy: Introduction to a pilot study of prognostic factor research in chronic cough. Indian J Res Homoeopathy 2020;14:200-10.
18Sathye SS. Evidence-based Homoeopathy: A case report of nodular episcleritis. Indian J Res Homoeopathy 2020;14:218-224.
19Sharma SS, Mahesh S, Vithoulkas G. Management of post--intubation subglottic stenosis with individualised homoeopathic therapy: A case report. Indian J Res Homoeopathy 2020;14:211-17.
20Pandey S. Research highlights (January 2020–May 2020). Indian J Res Homoeopathy 2020;14:225-27.
21To KL. Simplify the complexity and replicate the simplicity: Book review of standard treatment guidelines in Homoeopathy. Indian J Res Homoeopathy 2020;14:228-29.